| Literature DB >> 27747229 |
D Rolski1, J Kostrzewa-Janicka1, P Zawadzki2, K Życińska3, E Mierzwińska-Nastalska1.
Abstract
Morphological and functional disturbances induced by postsurgical defects and loss of tissues in the stomatognathic system due to the treatment of tumors in the maxillofacial region determine the therapeutic needs of patients. The study aimed at clinical and epidemiological evaluation of patients under prosthetic treatment in order to establish the algorithm for rehabilitation. The study group was composed of the patients after midface surgery (45.74%); surgery in a lower part of the face (47.38%); mixed postoperative losses (3.44%); loss of face tissues and surgery in other locations in the head and neck region (3.44%). The supplementary treatment was applied in 69.63% of patients. Clinical and additional examinations were performed to obtain the picture of postoperative loss, its magnitude, and location to plan the strategy of prosthetic rehabilitation. The management algorithm for prosthetic rehabilitation in patients after surgical treatment of maxillofacial neoplasms was based on its division in stages. The location and magnitude of postoperative losses, as well as the implementation of supplementary treatment of the patients after treatment of maxillofacial tumors, influence the planning of prosthetic rehabilitation that plays a key role and facilitates the patients' return to their prior living situation, occupational and family lives.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27747229 PMCID: PMC5056238 DOI: 10.1155/2016/4045329
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Baseline characteristics.
| % ( |
| |
|---|---|---|
|
| 12–93 years | 58.36 ± 7.56 |
|
| ||
|
| ||
| Female | 44.33 (219/494) | |
| Male | 55.67 (275/494) | |
|
| ||
|
| ||
| Group I | 44.75 (226/495) | |
| Bone loss1 | 92.03 (208/226) | |
| Class I | 41.83 (87/208) | |
| Class II | 27.41 (57/208) | |
| Class III | 6.73 (14/208) | |
| Class IV | 8.17 (17/208) | |
| Class V | 2.88 (6/208) | |
| Class VI | 12.98 (27/208) | |
| Group II | 47.37 (234/494) | |
| Bone loss2 | 69.23 (162/234) | |
| Class A | 40.12 (65/162) | |
| A1 | 40.00 (26/65) | |
| A2 | 46.15 (30/65) | |
| A3 | 13.85 (9/65) | |
| Class B | 27.16 (44/162) | |
| B1 | 9.09 (4/44) | |
| B2 | 75.00 (33/44) | |
| B3 | 15.91 (7/44) | |
| Class C | 32.72 (53/162) | |
| C1 | 94.34 (50/53) | |
| C2 | 5.66 (3/53) | |
| C3 | 0.00 (0/53) | |
| Group III | 3.44 (17/494) | |
| Group IV | 3.44 (17/494) | |
|
| ||
|
| 69.63 (344/494) | |
| Radiotherapy | 85.47 (294/344) | |
| Chemotherapy | 4.65 (16/344) | |
| Radio- and chemotherapy | 9.88 (34/344) | |
|
| ||
|
| ||
| Squamous carcinoma | 66.40 (328/494) | |
| Ameloblastoma | 3.24 (16/494) | |
| Tumor mixtus | 2.43 (12/494) | |
| Adenocarcinoma | 2.02 (10/494) | |
| Other | 25.91 (128/494) | |
1Aramany's classification; 2Furuta classification.
Number of patients subjected to prosthetic treatment after surgical removal of tumors in the head and neck region by the years of observation.
| Years of observation | Patients ( | Location of tumors | |||
|---|---|---|---|---|---|
| Group I ( | Group II ( | Group III ( | Group IV ( | ||
| 1999–2002 | 36 | 19 | 13 | 2 | 2 |
| 2003–2006 | 137 | 64 | 59 | 8 | 6 |
| 2007–2010 | 191 | 93 | 87 | 4 | 7 |
| 2011–2013 | 130 | 50 | 75 | 3 | 2 |
|
| |||||
| Total | 494 | 226 | 234 | 17 | 17 |
Characteristics of postoperative patients classified for prosthetic rehabilitation.
| Postoperative bone loss | Prosthetic characteristics | % ( |
|---|---|---|
| Group I | 93.03 (208/226) | |
| Reconstruction of bone loss in maxilla | 6.73 (14/208) | |
| Postoperative bone loss in maxilla | 93.27 (194/208) | |
|
| ||
| Group II | 69.23 (162/234) | |
| Reconstruction of bone loss in mandible | 21.61 (35/162) | |
| Postoperative bone loss in mandible | 78.39 (127/162) | |
|
| ||
| Group III | 3.44 (17/494) | |
| Reconstruction of bone loss in maxilla & mandible | 5.88 (1/17) | |
| Postoperative bone loss | 94.12 (16/17) | |